The standard of care for cancer patients at the UW Carbone Cancer Center (UWCCC) optimally involves a multidisciplinary team approach. The translation of laboratory discovery to clinical application is facilitated by multidisciplinary Disease Oriented Teams (DOTs). DOTs are embedded in specific UWCCC Scientific Programs and provide a multidisciplinary translational infrastructure which fosters inter- and intra-programmatic interactions that address programmatic goals and also disease specific interests. Each DOT has a designated leader and participants include UWCCC Scientific Program members, research staff and other UW faculty.
DOTs meet regularly and interested laboratory research faculty are encouraged to actively participate. In this manner, the multidisciplinary patient care activities and their associated clinical trials research are integrated into the Scientific Programs in several meaningful and functional ways through UWCCC faculty participation and UWCCC administrative support.
DOTs review and prioritize their respective clinical research activity and provide ongoing planning for new investigator-initiated studies. Proposed studies must have the support of the DOT prior to submission to the Protocol Review and Monitoring Committee (PRMC).
Contact the DOT leader or program manager for more information.
|Disease Oriented Teams
|Brain and CNS (XT)||Dr. John Kuo||Diana Trask|
|Breast and Melanoma (XT)||Tammy Koehn|
|Chemoprevention (CP)||Dr. Howard Bailey||Kelly Miller|
|Gastrointestinal Cancers (XT)||Caitlin Cleary|
|Genitourinary Cancers (XT)||Dr. Glenn Liu||Mary Jane Staab|
|Gynecological Cancers (XT)||Dr. Lisa Barroilhet||Claire Kostechka|
|Head and Neck (XT)||Dr. Paul Harari
|Hematologic Malignancies (XT)||Dr. Mark Juckett||Erica Barnstable|
|Thoracic (XT)||Dr. Ticiana Leal||Abigail Mapes|
|'OMA (XT)||Dr. Natalie Callander||Heather Neils|
|Palliative Medicine (CC)||Renae Quale|
|Pediatric Oncology (XT)||Dr. Kenneth De Santes||Jenny Weiland|
|Cancer Therapy Discovery and Development (XT)|
|Radiotherapy (XT)||Dr. Paul Harari||Diana Trask|
|Translational Imaging Research Working Group (IR)||Dr. Robert Jeraj||OTRS Office|
CC: Cancer Control